TROPION-Lung01: Dato-DXd in Previously Treated Advanced NSCLC

Solange Peters, MD, PhD, reviews key data from TROPION-Lung01 investigating datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced non–small cell lung cancer.

Related Keywords

Solange Peters , ,Evolving Treatment Paradigm ,Advanced Non ,Small Cell Lung Cancer ,Previously Treated Advanced ,Non Small Cell Lung Cancer ,Nsclc ,Advanced Non Small Cell Lung Cancer ,Advanced Nsclc ,Nsclc Treatment ,Non Small Cell Lung Cancer Treatment ,Udocetaxel ,Datopotamab Deruxtecan ,Toxicity ,